CenExel Clinical Research Acquires ForCare Clinical Research
Salt Lake City, Utah, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., ( CenExel ) announces the acquisition of ForCare Clinical Research (CenExel FCR), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience.
- Salt Lake City, Utah, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., ( CenExel ) announces the acquisition of ForCare Clinical Research (CenExel FCR), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience.
- The many strengths at CenExel FCR align perfectly with CenExels mission to be the leader in therapeutically focused clinical research.
- CenExel Clinical Research, Inc. was formed in 2018, and since its formation, CenExel has energetically pursued organic growth as well as the acquisitions of state-of-the-art research centers around the U.S.
- CenExel Clinical Research ( www.Cenexel.com ) provides unparalleled medical and scientific support in the design and execution of clinical trials.